Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-05-28

FDA Approved: LOSARTAN POTASSIUM 25 MG — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

The FDA approved a supplemental application for Losartan Potassium 25 mg (generic) by Strides Pharma Science Limited, enabling the generic product to be markete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan Potassium 25 mg (Losartan potassium)

Snippet

SUPPL AP for LOSARTAN POTASSIUM 25 MG (LOSARTAN POTASSIUM)